Jurisdiction | Restriction | ||||
---|---|---|---|---|---|
Minimum fibrosis stage required | Substance use | HIV coinfection | Prescriber | Decompensated cirrhosis | |
Province/territory | |||||
British Columbia | F2 | None listed* | Eligible | General practitioner | May be considered |
Alberta | F2 | None listed | Eligible | General practitioner | May be considered |
Saskatchewan | F2 | None listed† | Eligible | General practitioner | May be considered |
Manitoba | F2 | None listed | Eligible | Specialist | May be considered |
Ontario | F2 | None listed | Eligible | General practitioner | May be considered |
Quebec | None listed‡ | None listed | Ineligible§ | None listed | None listed |
New Brunswick | F2 | None listed | Eligible | Specialist | May be considered |
Nova Scotia | ≥ F2 | None listed | Eligible | General practitioner | May be considered¶ |
Prince Edward Island | NA | NA | NA | NA | NA |
Newfoundland and Labrador | F2 | None listed | Eligible | General practitioner | None listed |
Yukon | F2 | None listed | Eligible | Specialist | May be considered |
Northwest Territories | F2 | None listed | None listed | General practitioner | None listed |
Nunavut | F2 | None listed | None listed | General practitioner | None listed |
Federal | |||||
Non-Insured Health Benefits Program | F2 | None listed | None listed | General practitioner | None listed |
Correctional Service Canada | F2** | None listed†† | None listed | None listed | None listed |
Note: NA = not available.
*No specific criteria, but exclusion criteria state: "Patients who are at high risk for non-compliance."
†However, prescriber could indicate that directly observed therapy was recommended; also, the patient consented (via signature) to understanding treatment adherence.
‡However, coauthors indicated that in practice there were no fibrosis stage restrictions.
§However, exceptions could be granted via the "patient d'exception" (exception patient) measure.
¶Source: coauthor.
**Treatment prioritized to patients with stage F3 or F4 fibrosis; treatment for those with stage F0, F1 or F2 fibrosis was reviewed on a case-by-case basis.
††Directly observed therapy required.